Detalhe da pesquisa
1.
Long-term safety and effectiveness of roflumilast cream 0.3% in adults with chronic plaque psoriasis: A 52-week, phase 2, open-label trial.
J Am Acad Dermatol
; 2024 Mar 29.
Artigo
Inglês
| MEDLINE | ID: mdl-38556093
2.
INDIVIDUAL ARTICLE: Antibiotic Stewardship in Acne: 2023 Update.
J Drugs Dermatol
; 23(2): SF37896s4-SF378969s10, 2024 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38306149
3.
Benefit of Topical Combination Therapy for Acne: Analyzing Effect Size Using Number Needed to Treat.
J Drugs Dermatol
; 23(2): 42-49, 2024 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38306147
4.
Early and Sustained Acne Lesion Reductions With Fixed-Dose Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel.
J Drugs Dermatol
; 23(3): 125-131, 2024 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38443130
5.
Trial of Roflumilast Cream for Chronic Plaque Psoriasis.
N Engl J Med
; 383(3): 229-239, 2020 07 16.
Artigo
Inglês
| MEDLINE | ID: mdl-32668113
6.
Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb study.
Br J Dermatol
; 189(4): 392-399, 2023 09 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37279795
7.
Triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel for moderate-to-severe acne in children and adolescents: Randomized phase 2 study.
Pediatr Dermatol
; 40(3): 452-459, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36949579
8.
Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials.
JAMA
; 328(11): 1073-1084, 2022 09 20.
Artigo
Inglês
| MEDLINE | ID: mdl-36125472
9.
Oral Sarecycline for Treatment of Papulopustular Rosacea: Results of a Pilot Study of Effectiveness and Safety.
J Drugs Dermatol
; 20(4): 426-431, 2021 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33852248
10.
INDIVIDUAL ARTICLE: Safety and Tolerability of Topical Agents for Actinic Keratosis: A Systematic Review of Phase 3 Clinical Trials.
J Drugs Dermatol
; 20(10): s4s4-s14, 2021 Oct 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34636523
11.
ARTICLE: Advances in Oral Isotretinoin Therapy.
J Drugs Dermatol
; 20(5): s5-s11, 2021 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33938693
12.
Treatment of Impetigo and Antimicrobial Resistance.
J Drugs Dermatol
; 20(4): 366-372, 2021 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33852242
13.
Four-Week Daily Calcipotriene/Betamethasone Dipropionate Foam Is Highly Efficacious in Patients With Psoriasis (PSO-LONG Lead-in Phase).
J Drugs Dermatol
; 20(4): 436-441, 2021 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33852252
14.
ARTICLE: A Novel Antibiotic Just for Acne.
J Drugs Dermatol
; 19(11): s5, 2020 Nov 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33196745
15.
Game Changer in Acne Treatment.
J Drugs Dermatol
; 19(3): 28, 2020 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32550698
16.
The New Psoriasis Paradigm: Striving for Complete Clearance.
J Drugs Dermatol
; 19(6): 652-656, 2020 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32574025
17.
Oral Tetracyclines and Acne: A Systematic Review for Dermatologists.
J Drugs Dermatol
; 19(11): s6-s13, 2020 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33196746
18.
Efficacy and Safety of Calcipotriene 0.005%/Betamethasone Dipropionate 0.064% Foam With Apremilast for Moderate Plaque Psoriasis.
J Drugs Dermatol
; 19(9): 874-880, 2020 Sep 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33026749
19.
Androgens, Androgen Receptors, and the Skin: From the Laboratory to the Clinic With Emphasis on Clinical and Therapeutic Implications.
J Drugs Dermatol
; 19(3): 30-35, 2020 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32550699
20.
Evaluation of Patient-Reported Outcomes With Etanercept in Moderate to Severe Plaque Psoriasis Patients After Therapy With Apremilast.
J Drugs Dermatol
; 19(4): 378-383, 2020 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32272514